Sitemap

Sitemap

References:
  1. National Osteoporosis Society. Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. April 2013. https://nos.org.uk/document.doc?id=1352. Accessed August 2018.
  2. Consilient Health Ltd. InVita D3 50,000 IU oral solution Summary of Product Characteristics.
  3. Consilient Health Ltd. InVita D3 50,000 IU soft capsules Summary of Product Characteristics.
  4. Consilient Health Ltd. InVita D3 25,000 IU oral solution Summary of Product Characteristics.
  5. Consilient Health Ltd. InVita D3 25,000 IU soft capsules Summary of Product Characteristics.
  6. Consilient Health Ltd. InVita D3 5,600 IU soft capsules Summary of Product Characteristics.
  7. Consilient Health Ltd. InVita D3 800 IU soft capsules Summary of Product Characteristics.
  8. Consilient Health Ltd. InVita D3 2,400 IU oral drops. Summary of Product Characteristics.
  9. Consilient Health Ltd. InVita D3 400 IU soft capsules Summary of Product Characteristics.
Reporting of side effects:

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to Consilient Health (UK) Ltd, Ground Floor, No. 1 Church Road, Richmond upon Thames, Surrey TW9 2QE UK or drugsafety@consilienthealth.com.

This website is developed and funded by Consilient Health Ltd.
Copyright © 2018 Consilient Health. All rights reserved. Web agency GlobalizeMe.

UK-INV-226h Date of preparation: March 2021